Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-24

Clinical Trial Update: Asiaticoside for Treating Overweight/Obesity [NA]

View source ↗

Summary

A clinical trial registered in China is evaluating asiaticoside for overweight and obesity and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asiaticoside (Asiaticoside)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Overweight , Obesity | NA | Status: RECRUITING